1254073-62-5 Usage
General Description
2,3-dichloro-4-methylbenzoic acid is a compound with the chemical formula C8H6Cl2O2. It is a derivative of benzoic acid, with chlorine atoms substituting for hydrogen atoms at the 2 and 3 positions, and a methyl group at the 4 position. 2,3-dichloro-4-methylbenzoic acid is a white crystalline powder that is used in the synthesis of pharmaceuticals and agrochemicals. It is also used as a herbicide and pesticide in agricultural applications. 2,3-dichloro-4-methylbenzoic acid is a carboxylic acid, meaning it has a functional group consisting of a carbonyl group bonded to a hydroxyl group, and it is an important intermediate in the production of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1254073-62-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,4,0,7 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1254073-62:
(9*1)+(8*2)+(7*5)+(6*4)+(5*0)+(4*7)+(3*3)+(2*6)+(1*2)=135
135 % 10 = 5
So 1254073-62-5 is a valid CAS Registry Number.
1254073-62-5Relevant articles and documents
5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
-
Page/Page column 96-97, (2010/11/17)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein A is hydrogen, C1-4alkyl, C3-6cycloalkyl, C1-3alkoxy, C1-3alkoxy C1-4alkyl, C1-2fluoroalkyl, halogen, NR6 R7, optionally substituted heteroaryl (Het), or optionally substituted phenyl, and R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The compounds or salts are thought to modulate P2X7 receptor function and to be capable of antagonizing the effects of ATP at the P2X7 receptor. The invention also provides the use of the compound or salt in the treatment or prophylaxis of, for example, inflammatory pain, neuropathic pain, visceral pain, rheumatoid arthritis, osteoarthritis or neurodegenerative disorders.
